What’s new at Osteoboost

Osteoboost Health, Inc., today announced it has closed an $8 million financing round to scale manufacturing, expand clinical research, and broaden...

Osteoboost Health, Inc. and Midi Health will co-host a free public webinar, HRT and the New Science of Strong Bones...

October 21, 2025, REDWOOD CITY, CALIF — A new study to be presented at The Menopause Society (TMS) 2025 Annual Meeting by Osteoboost Health...

A 12-month randomized, sham-controlled clinical trial has found that Osteoboost, the first and only FDA-cleared prescription medical device for low...

Osteoboost Health, Inc today announced the nationwide availability of Osteoboost, the first and only FDA-cleared prescription medical device for...

Osteoboost Health Inc. today announced that the United States Patent and Trademark Office (USPTO) has awarded U.S. Patent No. 12,232,993 for...

Bone Health Technologies (BHT), a leading medical technology startup developing innovative non-pharmacological solutions to improve bone health and...

One of the biggest challenges of aging is the loss of bone density, which too often leads to osteoporosis and serious fractures that significantly...

Bone Health Technologies (BHT), a leading medical technology innovator developing breakthrough non-pharmacological solutions to improve bone health...

Bone Health Technologies (BHT), a leading medtech innovator developing breakthrough noninvasive and drug-free solutions for low bone density, today...

Bone Health Technologies (BHT), a health technology innovator developing breakthrough non-invasive solutions for bone health, today announced the...

Bone Health Technologies today announced that the U.S. Food and Drug Administration (FDA) has granted clearance for OsteoboostTM, the first...